Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00722254

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:15.733759+00:00

Published At

2016-03-21T00:00:00+00:00

Record Updated At

2016-03-21

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Primary Myelofibrosis", "Primary Pulmonary Hypertension", "Secondary Myelofibrosis", "Pulmonary Arterial Hypertension"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2016-03-21"

protocolSection.identificationModule.nctId

"NCT00722254"

protocolSection.identificationModule.officialTitle

"Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Primary Myelofibrosis (protocolSection.conditionsModule.conditions)
• Primary Pulmonary Hypertension (protocolSection.conditionsModule.conditions)
• Secondary Myelofibrosis (protocolSection.conditionsModule.conditions)
• Pulmonary Arterial Hypertension (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.